{"id":"https://openalex.org/W2294883787","doi":"https://doi.org/10.1182/blood.v88.7.2699.bloodjournal8872699","title":"Activating mutations of N- and K-ras in multiple myeloma show different clinical associations: analysis of the Eastern Cooperative Oncology Group Phase III Trial","display_name":"Activating mutations of N- and K-ras in multiple myeloma show different clinical associations: analysis of the Eastern Cooperative Oncology Group Phase III Trial","publication_year":1996,"publication_date":"1996-10-01","ids":{"openalex":"https://openalex.org/W2294883787","doi":"https://doi.org/10.1182/blood.v88.7.2699.bloodjournal8872699","mag":"2294883787","pmid":"https://pubmed.ncbi.nlm.nih.gov/8839865"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v88.7.2699.bloodjournal8872699","doi":"https://doi.org/10.1182/blood.v88.7.2699.bloodjournal8872699","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v88.7.2699.bloodjournal8872699","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5000035257","display_name":"P Liu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I130238516","display_name":"University of Minnesota","ror":"https://ror.org/017zqws13","country_code":"US","type":"education","lineage":["https://openalex.org/I130238516"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P Liu","raw_affiliation_strings":["University of Minnesota, Minneapolis, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Minnesota, Minneapolis, USA","institution_ids":["https://openalex.org/I130238516"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018311470","display_name":"Traci L. Leong","orcid":"https://orcid.org/0000-0003-2347-4260","observed_orcids":["https://orcid.org/0000-0003-2347-4260"]},"institutions":[{"id":"https://openalex.org/I130238516","display_name":"University of Minnesota","ror":"https://ror.org/017zqws13","country_code":"US","type":"education","lineage":["https://openalex.org/I130238516"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"T Leong","raw_affiliation_strings":["University of Minnesota, Minneapolis, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Minnesota, Minneapolis, USA","institution_ids":["https://openalex.org/I130238516"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080694232","display_name":"Lois Quam","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I130238516","display_name":"University of Minnesota","ror":"https://ror.org/017zqws13","country_code":"US","type":"education","lineage":["https://openalex.org/I130238516"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"L Quam","raw_affiliation_strings":["University of Minnesota, Minneapolis, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Minnesota, Minneapolis, USA","institution_ids":["https://openalex.org/I130238516"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080426319","display_name":"Daniel D. Billadeau","orcid":"https://orcid.org/0000-0002-2296-9547","observed_orcids":["https://orcid.org/0000-0002-2296-9547"]},"institutions":[{"id":"https://openalex.org/I130238516","display_name":"University of Minnesota","ror":"https://ror.org/017zqws13","country_code":"US","type":"education","lineage":["https://openalex.org/I130238516"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D Billadeau","raw_affiliation_strings":["University of Minnesota, Minneapolis, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Minnesota, Minneapolis, USA","institution_ids":["https://openalex.org/I130238516"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002515721","display_name":"Neil E. Kay","orcid":"https://orcid.org/0000-0002-5951-5055","observed_orcids":["https://orcid.org/0000-0002-5951-5055"]},"institutions":[{"id":"https://openalex.org/I130238516","display_name":"University of Minnesota","ror":"https://ror.org/017zqws13","country_code":"US","type":"education","lineage":["https://openalex.org/I130238516"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"NE Kay","raw_affiliation_strings":["University of Minnesota, Minneapolis, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Minnesota, Minneapolis, USA","institution_ids":["https://openalex.org/I130238516"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003514918","display_name":"PR Greipp","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I130238516","display_name":"University of Minnesota","ror":"https://ror.org/017zqws13","country_code":"US","type":"education","lineage":["https://openalex.org/I130238516"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P Greipp","raw_affiliation_strings":["University of Minnesota, Minneapolis, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Minnesota, Minneapolis, USA","institution_ids":["https://openalex.org/I130238516"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023193953","display_name":"Robert A. Kyle","orcid":"https://orcid.org/0000-0003-4763-4580","observed_orcids":["https://orcid.org/0000-0003-4763-4580"]},"institutions":[{"id":"https://openalex.org/I130238516","display_name":"University of Minnesota","ror":"https://ror.org/017zqws13","country_code":"US","type":"education","lineage":["https://openalex.org/I130238516"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"RA Kyle","raw_affiliation_strings":["University of Minnesota, Minneapolis, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Minnesota, Minneapolis, USA","institution_ids":["https://openalex.org/I130238516"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109268161","display_name":"Martin M. Oken","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I130238516","display_name":"University of Minnesota","ror":"https://ror.org/017zqws13","country_code":"US","type":"education","lineage":["https://openalex.org/I130238516"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"MM Oken","raw_affiliation_strings":["University of Minnesota, Minneapolis, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Minnesota, Minneapolis, USA","institution_ids":["https://openalex.org/I130238516"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111749625","display_name":"Brian Van Ness","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I130238516","display_name":"University of Minnesota","ror":"https://ror.org/017zqws13","country_code":"US","type":"education","lineage":["https://openalex.org/I130238516"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"B Van Ness","raw_affiliation_strings":["University of Minnesota, Minneapolis, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Minnesota, Minneapolis, USA","institution_ids":["https://openalex.org/I130238516"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I130238516"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":3.277,"has_fulltext":false,"cited_by_count":215,"citation_normalized_percentile":{"value":0.92686608,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":100},"biblio":{"volume":"88","issue":"7","first_page":"2699","last_page":"2706"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9940000176429749},{"id":"https://openalex.org/keywords/nras-mutation","display_name":"NRAS mutation","score":0.8119999766349792},{"id":"https://openalex.org/keywords/kras-mutation","display_name":"KRAS mutation","score":1.0},{"id":"https://openalex.org/keywords/oncogenic-ras","display_name":"oncogenic Ras","score":0.6150000095367432},{"id":"https://openalex.org/keywords/codon-12-and-13-mutations","display_name":"codon 12 and 13 mutations","score":0.7860000133514404},{"id":"https://openalex.org/keywords/disease-progression","display_name":"disease progression","score":0.6150000095367432},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.972000002861023},{"id":"https://openalex.org/keywords/interferon-alpha","display_name":"interferon-alpha","score":0.7409999966621399},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.7770000100135803}],"concepts":[{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.6243382692337036},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.6218358278274536},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5913271307945251},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5751590728759766},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.44363266229629517},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.44126972556114197},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.4307793378829956},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.37284010648727417},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.26870882511138916},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.1976848542690277},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.15103977918624878},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001853","descriptor_name":"Bone Marrow","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D002330","descriptor_name":"Carmustine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002999","descriptor_name":"Clone Cells","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D003062","descriptor_name":"Codon","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D003131","descriptor_name":"Combined Modality Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004252","descriptor_name":"DNA Mutational Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004273","descriptor_name":"DNA, Neoplasm","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007155","descriptor_name":"Immunologic Factors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008558","descriptor_name":"Melphalan","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D011241","descriptor_name":"Prednisone","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011905","descriptor_name":"Genes, ras","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D012150","descriptor_name":"Polymorphism, Restriction Fragment Length","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014750","descriptor_name":"Vincristine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D015993","descriptor_name":"Life Tables","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016019","descriptor_name":"Survival Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1182/blood.v88.7.2699.bloodjournal8872699","doi":"https://doi.org/10.1182/blood.v88.7.2699.bloodjournal8872699","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v88.7.2699.bloodjournal8872699","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},{"id":"pmid:8839865","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8839865","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1933767249","display_name":null,"funder_award_id":"CA32218","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G2258688219","display_name":null,"funder_award_id":"CA 15947","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G6444238965","display_name":null,"funder_award_id":"CA19853","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":37,"referenced_works":["https://openalex.org/W22172272","https://openalex.org/W66769261","https://openalex.org/W75558007","https://openalex.org/W77810648","https://openalex.org/W151744451","https://openalex.org/W177142271","https://openalex.org/W178019285","https://openalex.org/W1505669067","https://openalex.org/W1510833310","https://openalex.org/W1583035638","https://openalex.org/W1932261119","https://openalex.org/W1971982788","https://openalex.org/W1993378834","https://openalex.org/W1996027687","https://openalex.org/W2007000374","https://openalex.org/W2018022369","https://openalex.org/W2021138676","https://openalex.org/W2027428062","https://openalex.org/W2032013475","https://openalex.org/W2052490105","https://openalex.org/W2059162919","https://openalex.org/W2077423482","https://openalex.org/W2087441022","https://openalex.org/W2091723114","https://openalex.org/W2097873933","https://openalex.org/W2125991735","https://openalex.org/W2140584440","https://openalex.org/W2159466824","https://openalex.org/W2159594827","https://openalex.org/W2176790322","https://openalex.org/W2262776735","https://openalex.org/W2395919070","https://openalex.org/W2401075461","https://openalex.org/W2402284595","https://openalex.org/W2411767620","https://openalex.org/W2417644702","https://openalex.org/W2463411948"],"related_works":["https://openalex.org/W7217215059","https://openalex.org/W2356217487","https://openalex.org/W1968111572","https://openalex.org/W2395919070","https://openalex.org/W4417221854","https://openalex.org/W7116975787","https://openalex.org/W7036805649","https://openalex.org/W1998392339","https://openalex.org/W2402284595","https://openalex.org/W2003442933"],"abstract_inverted_index":{"Mutations":[0],"of":[1,3,25,59,67,75,90,110,125,144,158,179,221,242,258,263,283,307,316,328,339],"members":[2],"the":[4,9,22,26,45,68,88,107,111,142,218,240,254,261,268,278,281],"ras":[5,60,98,108,133,139,154,187,209,243,265,294,322,334],"family":[6],"are":[7],"among":[8],"most":[10],"common":[11],"oncogene":[12],"mutations":[13,61,178,193,210,244,323],"found":[14,63,119],"in":[15,37,267,305],"multiple":[16],"myeloma":[17],"(MM).":[18],"We":[19,80],"have":[20],"examined":[21,250],"mutational":[23],"status":[24,241],"N-":[27],"and":[28,35,156,172,217,292,312],"K-ras":[29,192,225],"genes":[30],"at":[31,87,102,120,135,141,203],"codons":[32],"12,":[33],"13,":[34],"61":[36],"160":[38],"newly":[39],"diagnosed":[40],"MM":[41],"patients":[42,72,86,127,176,184,190,206,222,308,331],"enrolled":[43],"on":[44,253],"Eastern":[46],"Cooperative":[47],"Oncology":[48],"Group":[49],"(ECOG)":[50],"phase":[51],"III":[52],"clinical":[53],"trial":[54],"E9486.":[55,259],"The":[56,168],"total":[57],"incidence":[58],"was":[62,100,115,150,181,227],"to":[64,117,299],"be":[65,300],"39%":[66],"samples":[69,84],"analyzed.":[70],"Five":[71],"showed":[73,273,285],"evidence":[74],"more":[76],"than":[77,205],"one":[78],"mutation.":[79],"obtained":[81],"22":[82],"marrow":[83,200],"from":[85,183],"time":[89,143],"disease":[91,112,145],"progression":[92,113],"or":[93,165],"relapse,":[94],"for":[95,175],"whom":[96],"a":[97,138,195,224,264,274,301,325,336],"mutation":[99,109,134,140,155,226,266],"identified":[101],"diagnosis.":[103,121],"In":[104,122],"all":[105],"cases,":[106],"sample":[114],"identical":[116],"that":[118],"contrast,":[123],"three":[124,255],"25":[126],"who":[128],"did":[129],"not":[130],"show":[131],"any":[132,153],"diagnosis":[136,204],"acquired":[137],"progression.":[146],"No":[147],"significant":[148,287,303],"association":[149],"observed":[151],"between":[152,290],"stage":[157],"disease,":[159],"beta":[160],"2-microglobulin":[161],"levels,":[162],"labelling":[163],"index,":[164],"protein":[166],"type.":[167],"mean":[169,198],"tumor":[170,201],"burden":[171,202],"median":[173,219,326,337],"survival":[174,220,252,288,306,327,338],"with":[177,185,191,207,223,310,321,332],"N-ras":[180],"indistinguishable":[182],"no":[186,208],"mutations.":[188],"However,":[189],"had":[194,324,335],"significantly":[196,228],"higher":[197],"bone":[199],"(57%":[211],"v":[212,231],"36%,":[213],"P":[214,234],"<":[215,235,343],".02);":[216],"shorter":[229],"(2.0":[230],"3.7":[232],"years,":[233],".02).":[236],"To":[237],"determine":[238],"if":[239],"could":[245],"affect":[246],"treatment":[247,256],"response,":[248],"we":[249],"patient":[251],"arms":[257],"Although":[260],"presence":[262],"multidrug":[269],"treatment,":[270],"VBMCP":[271,311],"alone,":[272],"marginal":[275],"significance,":[276],"neither":[277],"VBMCP,":[279],"nor":[280],"addition":[282],"interferon-alpha":[284],"statistically":[286,302],"differences":[289],"mutant":[291],"wildtype":[293],"status.":[295],"Interestingly,":[296],"there":[297],"appeared":[298],"difference":[304],"treated":[309],"alternating":[313],"high":[314],"doses":[315],"cyclophosphamide":[317],"+":[318],"prednisone.":[319],"Patients":[320],"2.1":[329],"years;":[330],"wild-type":[333],"4.0":[340],"years":[341],"(P":[342],".01).":[344]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":15}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}